MoneyWorks4Me

Windlas Biotech - Quaterly Results

22 May 2025 Evaluate
A fair growth of 18.34% in the revenue at Rs. 2027.05 millions was reported in the March 2025 quarter as compared to Rs. 1712.85 millions during year-ago period.The Company's Net profit for the March 2025 quarter have declined marginally to Rs. 162.85  millions as against Rs. 169.49 millions reported during the corresponding quarter ended.Operating profit for the quarter ended March 2025 rose to 304.89 millions as compared to 263.75 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2027.05 1712.85 18.34 7598.78 6309.56 20.43 7598.78 6309.56 20.43
Other Income 49.41 44.40 11.28 176.46 134.68 31.02 176.46 134.68 31.02
PBIDT 304.89 263.75 15.60 1117.61 915.70 22.05 1117.61 915.70 22.05
Interest 13.27 2.76 380.80 43.82 11.03 297.28 43.82 11.03 297.28
PBDT 291.62 260.99 11.74 1073.79 904.67 18.69 1073.79 904.67 18.69
Depreciation 83.35 35.36 135.72 279.85 134.44 108.16 279.85 134.44 108.16
PBT 208.27 225.63 -7.69 793.94 770.23 3.08 793.94 770.23 3.08
TAX 45.42 56.14 -19.10 187.45 188.79 -0.71 187.45 188.79 -0.71
Deferred Tax -0.64 10.93 -105.86 4.72 15.35 -69.25 4.72 15.35 -69.25
PAT 162.85 169.49 -3.92 606.49 581.44 4.31 606.49 581.44 4.31
Equity 104.80 103.99 0.78 104.80 103.99 0.78 104.80 103.99 0.78
PBIDTM(%) 15.04 15.40 -2.32 14.71 14.51 1.34 14.71 14.51 1.34
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..